ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Cannabist Company Holdings Inc

Cannabist Company Holdings Inc (CBST)

0,08
0,005
( 6,67% )
Mis à jour : 17:51:57
Données en temps réel

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,08
Prix Achat
0,075
Prix Vente
0,08
Volume échangé
951 031
0,07 Fourchette du Jour 0,08
0,0675 Plage de 52 semaines 0,83
Clôture Veille
0,075
Ouverture
0,08
Dernière Transaction
3000
@
0.08
Dernière heure de transaction
17:57:10
Volume moyen (3 m)
714 634
Volume financier
-
VWAP
-

CBST Dernières nouvelles

Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint

Acquisitions Expand Verano’s Footprint to 14 States, 15 Cultivation and Production Facilities, and 150 Dispensaries Nationwide CHICAGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp...

Dana Holding Set to Join the S&P MidCap 400

Dana Holding Set to Join the S&P MidCap 400 PR Newswire NEW YORK, Jan. 20, 2015 NEW YORK, Jan. 20, 2015 /PRNewswire/ -- Dana Holding Corp. (NYSE: DAN) will replace Cubist Pharmaceuticals Inc...

Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated...

Cubist meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (Ceftolozan/Tazobactam) für komplizierte Harnwegsinfektion...

ZERBAXA geht bestimmte gefährliche und resistente gramnegative Bakterien anErstes in den USA unter dem GAIN-Gesetz zugelassenes Antibiotikum gegen gramnegative Bakterien Cubist...

Cubist annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des i...

ZERBAXA s’attaque à certaines bactéries à Gram négatif graves et résistantes Premier nouvel antibiotique approuvé aux États-Unis dans le cadre de la GAIN Act pour le traitement des...

Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract & Complicat...

ZERBAXA addresses certain serious and resistant Gram-negative bacteriaFirst new antibiotic approved in U.S. under the GAIN Act that treats Gram-negative bacteria Cubist...

Merck Begins Tender Offer to Acquire Cubist

Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. R...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company PR Newswire BALA...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over ...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc...

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourag...

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.080.090.067512316630.075CS
4-0.075-48.38709677420.1550.1550.06758310360.0863655CS
12-0.215-72.88135593220.2950.3550.06757146340.16190136CS
26-0.185-69.81132075470.2650.420.06755546210.22778952CS
52-0.49-85.96491228070.570.830.067510145020.43525513CS
156-1.6-95.23809523811.681.760.067510743130.54258874CS
260-1.6-95.23809523811.681.760.067510743130.54258874CS

CBST - Frequently Asked Questions (FAQ)

What is the current Cannabist share price?
The current share price of Cannabist is $ 0,08
What is the 1 year trading range for Cannabist share price?
Cannabist has traded in the range of $ 0,0675 to $ 0,83 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VERSVerses AI Inc
$ 1,49
(21,14%)
1,22M
BTQBTQ Technologies Corp
$ 3,96
(8,20%)
461,9k
CBSTCannabist Company Holdings Inc
$ 0,08
(6,67%)
951,03k
HOLDImmutable Holdings Inc
$ 0,105
(5,00%)
17,76k
JET.BGlobal Crossing Airlines Group Inc
$ 0,60
(1,69%)
5,52k
IFSSInterfield Global Software Inc
$ 0,02
(-42,86%)
6,22k
FHFilament Health Corp
$ 0,03
(-14,29%)
3k
CDMNCanadian Manganese Company Inc
$ 0,035
(-12,50%)
132,99k
GRAMGold Flora Corporation
$ 0,04
(-11,11%)
39,42k
NETZCarbon Streaming Corporation WTS B
$ 0,49
(-10,91%)
41,4k
VERSVerses AI Inc
$ 1,49
(21,14%)
1,22M
CBSTCannabist Company Holdings Inc
$ 0,08
(6,67%)
951,03k
BTQBTQ Technologies Corp
$ 3,96
(8,20%)
461,9k
DEFIValour Inc
$ 3,80
(-7,32%)
378,79k
BCBNBase Carbon Inc
$ 0,42
(1,20%)
157,7k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock